Detailed Quote
                     Questions on this company?
                                    Become a Member
                                                            Company Profile
                    {tplLang.businessdescription | toLang tLang}
                                    { profileData.description }
                                    
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
                                    {profileData.profile.details.ceo}
                                    {tplLang.employees | toLang tLang}
                                    {profileData.profile.details.employees | numeraljs '0,0'}
                                    {tplLang.issuetype | toLang tLang}
                                    {profileData.profile.details.issuetype | asIssueType}
                                    {tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
                                    {profileData.profile.classification.sector}
                                    {tplLang.industry | toLang tLang}
                                    {profileData.profile.classification.industry}
                                    {tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
                                            {data.symbolstring}.
                                    
                                    Interactive Chart
            Key Ratios
            Earnings
            Analyst Recommendations
                    5i Recent Questions
                            - 
        
                             Adaptive Biotechnologies Corporation (ADPT $17.41) Adaptive Biotechnologies Corporation (ADPT $17.41)- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT
 
            Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?
        
    - 
        
                             Adaptive Biotechnologies Corporation (ADPT $17.41) Adaptive Biotechnologies Corporation (ADPT $17.41)- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT
 
            Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?
Much appreciated,
        
    Much appreciated,
- 
        
                             Amgen Inc. (AMGN $294.26) Amgen Inc. (AMGN $294.26)- $294.26 P/E (TTM): 23.84X Cap: $157.20B
- View AMGN Profile
- View Questions on AMGN
 
- 
        
                             Johnson & Johnson (JNJ $188.12) Johnson & Johnson (JNJ $188.12)- $188.12 P/E (TTM): 19.96X Cap: $455.29B
- View JNJ Profile
- View Questions on JNJ
 
- 
        
                             Inovio Pharmaceuticals Inc. (INO $2.34) Inovio Pharmaceuticals Inc. (INO $2.34)- $2.34 Cap: $125M
- View INO Profile
- View Questions on INO
 
- 
        
                             Novavax Inc. (NVAX $8.39) Novavax Inc. (NVAX $8.39)- $8.39 P/E (TTM): 3.52X Cap: $1.38B
- View NVAX Profile
- View Questions on NVAX
 
- 
        
                             Repligen Corporation (RGEN $149.89) Repligen Corporation (RGEN $149.89)- $149.89 Cap: $8.13B
- View RGEN Profile
- View Questions on RGEN
 
- 
        
                             Moderna Inc. (MRNA $27.33) Moderna Inc. (MRNA $27.33)- $27.33 Cap: $10.94B
- View MRNA Profile
- View Questions on MRNA
 
- 
        
                             Adaptive Biotechnologies Corporation (ADPT $17.41) Adaptive Biotechnologies Corporation (ADPT $17.41)- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT
 
- 
        
                             Sorrento Therapeutics Inc. (SRNE) Sorrento Therapeutics Inc. (SRNE)- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE
 
            Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine
    Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine
Insiders
                    Share Information
                    SEC Filings
                        News and Media
                     
                             
                             
                    